Back to trial details

Intake questionnaire

A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.

Applying to Sarah Cannon Research Institute at HealthOne · Denver, Colorado

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you between 18 and 89 years old?
2. Have you been diagnosed with Advanced Solid Tumors?
3. Are you able to travel to Denver for study visits?